Pfizer (PFE) Dividend Coverage Ratio (2009 - 2026)
Pfizer's (PFE) quarterly Dividend Coverage Ratio came in at 0.1 in Q2 2026, down 108.11% year-over-year from 1.2 in Q2 2025, and down 108.81% quarter-over-quarter from 1.1 in Q1 2026.
Analysis
Pfizer (PFE) Dividend Coverage Ratio (2009 - 2026) Analysis & Trends
Pfizer (PFE) has reported Dividend Coverage Ratio for 18 consecutive years, with 0.1 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Dividend Coverage Ratio fell 108.11% year-over-year to 0.1 in Q2 2026; TTM through Jun 2026 was 0.45, a 52.69% decrease from a year earlier, with the FY2025 full-year figure at 0.8, down 5.68% from the prior year.
- Dividend Coverage Ratio was 0.1 for Q2 2026 at Pfizer, down from 1.1 in the prior quarter.
- Over five years, Dividend Coverage Ratio peaked at 4.42 in Q3 2022 and troughed at 1.45 in Q4 2023.
- A 5-year average of 1.18 and a median of 1.15 in 2025 frame the typical range for Dividend Coverage Ratio.
- Across the five-year window, Dividend Coverage Ratio jumped 5837.83% in 2025 and plunged 108.11% in 2026, its largest moves.
- Over 5 years, Dividend Coverage Ratio stood at 4.42 in 2022, then slumped by 132.86% to 1.45 in 2023, then surged by 173.73% to 1.07 in 2024, then slumped by 162.68% to 0.67 in 2025, then surged by 85.52% to 0.1 in 2026.
- The last three Dividend Coverage Ratio figures came in at 0.1 (Q2 2026), 1.1 (Q1 2026), and 0.67 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.12 Bn | 626.36 Bn | 17.26 Bn | 1.71 |
| 2 | AbbVie | 440.93 Bn | 434.36 Bn | 12.70 Bn | 1.18 |
| 3 | Merck | 364.34 Bn | 357.20 Bn | 12.21 Bn | -0.62 |
| 4 | Novartis Ag | 268.31 Bn | 260.62 Bn | 11.24 Bn | 1.14 |
| 5 | Pfizer | 158.49 Bn | 146.79 Bn | 10.94 Bn | -0.10 |
| 6 | Sanofi | 52.52 Bn | 45.14 Bn | 10.79 Bn | 0.07 |
| 7 | Revolution Medicines | 44.27 Bn | 44.27 Bn | - | - |
| 8 | Incyte | 25.01 Bn | 20.47 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.18 Bn | 18.51 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.40 Bn | 15.01 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | -0.10 |
| Mar 29, 2026 | 1.10 |
| Dec 31, 2025 | -0.67 |
| Sep 28, 2025 | 1.45 |
| Jun 29, 2025 | 1.20 |
| Mar 30, 2025 | 1.22 |
| Sep 29, 2024 | 1.07 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | 1.32 |
| Dec 31, 2023 | -1.45 |
| Jul 2, 2023 | 1.01 |
| Apr 2, 2023 | 2.41 |
| Jul 3, 2022 | 4.42 |
| Apr 3, 2022 | 3.50 |
| Oct 3, 2021 | 2.85 |
| Jul 4, 2021 | 2.56 |
| Apr 4, 2021 | 2.25 |
| Sep 27, 2020 | 1.32 |
| Jun 28, 2020 | 1.66 |
| Mar 29, 2020 | 1.60 |